|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Premier Biomedical Developing Revolutionary Medical Cures
8/3/2012 10:30:21 AM
JACKSON CENTER, Pa.--(BUSINESS WIRE)--Premier Biomedical, Inc. (OTCBB: BIEI) announced that they have begun trading on the OTC-BB fully reporting index at “BIEI”. Premier Biomedical Inc’s principal technology is based on the Felder Doctrine™, “To physically remove the pathophysiologic basis of the disease.” This revolutionary approach to medicine constitutes a micro-surgical eradication of the cause of a multitude of diseases and is designed to find cures for 19 of the most severe diseases, including Cancer, Alzheimer’s Disease, Leukemia, Heart Attacks, Strokes, ALS, and AIDS.
|
|
|
|
|
|
|
|
|
|
|